ASML reported Q2 2026 results on July 15 — and the earnings-day divergence that defined Tuesday's session has given way to a broad sector recovery, with peers snapping back sharply and the stock itself consolidating near €1,556.
The result matters most for what it signals about the order cycle. Heading into today's print, the previous note flagged that investors appeared to be treating this as a potential re-rating catalyst rather than a risk event — and the pre-earnings price action bore that out. ASML closed Tuesday up nearly 1% to €1,555.80, while LRCX dropped almost 6%, FORM fell more than 6%, and NVMI and MTSI both shed around 5%. The divergence was notable. Post-earnings, peers have reversed hard: LRCX bounced 4.9% on the day, FORM climbed 5.5%, NVMI added 4.6%, and surged nearly 7%. rose 4.3%. The sector is recovering into the result — which suggests the ASML print read as constructive for the equipment cycle broadly.
The lending market remains entirely disengaged from the short side. Borrow availability is effectively uncapped — over 218 million shares are available to lend, and the cost to borrow at 0.58% has fallen roughly 14% over the past week and more than 22% over the past month. That is one of the loosest borrow environments in the sector. The ORTEX short score of 25.2 ranks in the 96th percentile for being low, placing ASML among the least-shorted large-caps in the semiconductor equipment universe. Nothing in the lending picture changed around earnings — there was no late rush to establish short positions, no tightening in availability, no spike in cost to borrow. Bears simply are not present in any meaningful size.
On the Street, the analyst data on file is too dated to cite with confidence — the consensus snapshot is from mid-2023 and the picture has clearly shifted significantly since then. What the valuation multiples do show is a notable expansion over the past month: the P/E has climbed roughly 5 points over 30 days to around 45.5x, and the price-to-book has expanded by more than 3 points to 24.3x. These moves reflect the stock's recovery from the early-July pullback and an improving earnings backdrop. The EV/EBITDA, by contrast, has compressed slightly over the same window, sitting near 35.6x — a more modest picture that suggests the P/E expansion is partly earnings-driven rather than purely multiple re-rating.
Institutional ownership tells a stable story. BlackRock leads with 7.2% of shares, adding 336,000 shares as of June 30. FMR (Fidelity) added 238,000 shares over the same period, and Capital Research added 152,000. Van Eck — likely reflecting index and thematic ETF flows — added the most in relative terms, over 400,000 shares through June 30. There are no large sellers visible among the top holders. The ownership base is broadly constructive, with no sign of major de-risking ahead of today's result.
The next scheduled earnings date is October 14. Between now and then, the question shifts from "will the orders recover?" to "does the Q2 order beat translate into a sustained backlog build through H2" — and whether the sector-wide peer recovery that followed today's print holds as AI-driven capex plans firm up through the summer.
See the live data behind this article on ORTEX.
Open ASML on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
